Sublime
An inspiration engine for ideas
SARPAM recruited patients to use their smartphones to report the prices they paid for different drugs. When they found major differences for the same drug between, say, Angola and Zimbabwe, SARPAM would take the evidence to the government, which would use it to negotiate effectively for a lower price.
Joel Gurin • Open Data Now: The Secret to Hot Startups, Smart Investing, Savvy Marketing, and Fast Innovation (Business Books)
Media critic Howard Kurtz is one of the few noting the decidedly unjournalistic tone of the sordid saga. “Where are the corrections from everyone else who ran with this story?” he asks on his Fox News program, Media Buzz.
Sharyl Attkisson • The Smear: How Shady Political Operatives and Fake News Control What You See, What You Think, and How You Vote
On the one hand, the current market price implied that Sam’s Solana stash was worth maybe $12 billion; on the other hand, Sam owned roughly 10 percent of all the Solana in the world. It was hard to know what anyone would pay for it if Sam tried to sell it all. Forbes pretty much just ignored Sam’s Solana holdings, along with most of the rest of the
... See moreMichael Lewis • Going Infinite: The Rise and Fall of a New Tycoon
David Freedman, “Lies, Damned Lies, and Medical Science,” Atlantic, October 4, 2010, http://www.theatlantic.com/magazine/archive/2010/11/lies-damned-lies-and-medical-science/308269/.
Leslie F. Stebbins • Finding Reliable Information Online: Adventures of an Information Sleuth
roon is a member of the technical staff at OpenAI, or at least that’s how The Washington Post describes him.